Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Lixiana (edoxaban)
pCPA File Number:
20978
Negotiation Status:
Concluded with an LOI
Indication(s):
Venous thromboembolism, treatment and recurrence prevention
Sponsor/Manufacturer:
Servier Canada Inc.
CADTH Project Number:
SR0499
pCPA Engagement Letter Issued:
2018-07-20
Negotiation Process Concluded:
2019-02-05